Clinical Trial Update: Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) [Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 2 study evaluating ethosuximide for Complex regional pain syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Regional Pain Syndrome

Drugs mentioned

• Ethosuximide (ethosuximide)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Complex Regional Pain Syndromes | Phase 2 | Status: TERMINATED